Pfe stock price today intraday patterns reveal "PFE stock

Intraday patterns reveal "PFE stock price today" is benefiting from strong bid support at $27.70, making it a psychological support zone for active traders this week. The removal of uncertainty related to tariffs and MFN pricing that was looming over Pfizer's head is huge. While Pfizer said that "specific terms of the agreement remain confidential," the company's price cuts appear to be limited only to Medicaid and on the TrumpRx website for people without health insurance. Overall, the positives of Pfizer's agreement should outweigh the negatives for investors. Full details of the deal and how MFN works are still scarce. It is clear that Trump is easing IRP into the US by introducing MFN pricing into Medicaid first. Trump may introduce IRP into other government programmes in the future, and may reach the private market, though there are still several uncertainties in the announced deal. This includes uncertainty around how the MFN discounts in Medicaid will compare to the current discounts the program already gets, or how insurance will work on the TrumpRx website. The Trump administration hopes to launch TrumpRx and implement MFN pricing for Medicaid by early 2026. Pfizer CEO Albert Bourla had hailed the deal with the Trump administration and called it a win-win situation for Americans and Pfizer. Bourla pointed out he satisfied all four of Trump’s requests to lower drug costs in the US, based on the letter the Trump administration sent out in July. As of today, the "PFE stock price today" is trading around $27.85, showing a modest 0.42% uptick in early market hours. Analysts note that Pfizer’s recent Q1 earnings beat expectations, driven by strong vaccine and oncology portfolio sales, influencing short-term bullish sentiment.